# Pneumococcal Reference Standard

> **NCT00479323** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 250 (actual)

## Conditions studied

- Pneumococcal Infections

## Interventions

- **BIOLOGICAL:** Pneumovax 23

## Key facts

- **NCT ID:** NCT00479323
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2008-08
- **Final completion:** 2008-08
- **Target enrollment:** 250 (ACTUAL)
- **Last updated:** 2016-12-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00479323

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00479323, "Pneumococcal Reference Standard". Retrieved via AI Analytics 2026-08-23 from https://api.ai-analytics.org/clinical/NCT00479323. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*